NanoViricides (NNVC) Misses Q2 EPS by 1c

NanoViricides (NYSE: NNVC) reported Q2 EPS of ($0.18), $0.01 worse than the analyst estimate of ($0.17).

For earnings history and earnings-related data on NanoViricides (NNVC) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Qualcomm investor day to detail data center plans Wednesday